Dr.

John Cleary
Internal Medicine Risk Method CareScience® Analytics - Std Status Current
Premier Memorial, Charlotte Internal Peer Practitioners Timeframe Feb 2010 - Jul 2010
Role(s) Attending Practitioner External Peer Top QUEST Facilities Total Cases 164 of 164

Outcomes
MORTALITY O/E

Observed/
Cases Observed
Expected
My Performance 160 6.3 1.5

Internal Peer 2,146 4.1 1.1

External Peer 106,932 2.8 1.0

COMPLICATIONS O/E

Observed/
Cases Observed
Expected
My Performance 164 57.4% 1.2

Internal Peer 2,176 53.2% 1.1

External Peer 106,988 52.4% 1.1

LENGTH OF STAY O/E

Observed/
Cases Observed
Expected
My Performance 164 2.5 0.8

Internal Peer 2,172 2.4 0.8

External Peer 106,977 3.5 1.0

READMISSIONS Readmission Rate %

Readmission
Cases
Rate
My Performance 164 13.4%

Internal Peer 2,176 12.8%

External Peer 108,237 12.9%

COST PER CASE O/E

Observed/
Cases Observed
Expected
My Performance 161 $5,149 0.9

Internal Peer 2,154 $4,960 0.8

External Peer 106,155 $6,552 1.0

Exceeds target Meets target Fails to meet target My Performance Internal Peer External Peer

Confidential - Use Restricted by Agreement Created on 02/23/2011 Page 1 of 2

Dr. John Cleary
Procedures*
Internal Peer External Peer Internal Peer External Peer
Cases % Cases
% Cases % Cases Variation Variation
Venous catheterization NEC 15 100% 8% 9% 92% 91%
Contin invasive mech vent <96hrs 9 6% 6% 3% -1% 3%
Insert endotracheal tub 8 5% 6% 3% -1% 2%
Small intestine endoscopy NEC 7 3% 3% 3% 0% 0%
Hemodialysis 5 1% 3% 4% -2% -3%
EGD with closed biopsy 5 0% 2% 3% -2% -3%

Evidence Based Care*

Missed Internal Peer External Peer
Rate
Opportunities Rate Rate
ACEI or ARB for LVSD (HF-3) 1 50% 80% 90%
Evaluation of LVS Function (HF-2) 2 75% 90% 95%
Influenza vaccination (PN-7) 0 100% 100% 100%
Initial antibiotic selection for CAP in immunocompetent - Non ICU patient (PN-6b) 0 100% 100% 100%
Initial Antibiotic Received Within 6 Hours of Hospital Arrival (PN-5c) 0 100% 100% 100%
Adult smoking cessation advice / counseling (PN-4) 0 100% 100% 100%

Premier Complications* Patient Safety Indicators*

Internal External Internal External
Rate Rate
Peer Peer Peer Peer
Catheter Associated UTI 1% 2% 2% Postop Sepsis 100% 7% 3%

Postop Respiratory Failure 100% 4% 8%

Death in Surgical Pts w Treatable 50% 21% 12%

Resources*
External Peer Quantity per Internal Peer External Peer
Internal Peer % Use Resource Quantity Quantity
% Use % Use Variation Variation Case Variation Variation
Microbial culture, aerobic, initial isolation (procedure) 30% 10% 16% 1.1 -0.3 -0.7
ABO blood grouping (procedure) 24% 7% 3% 1.1 0.0 -0.3
Laxatives [drug category] 12% 7% 7% 4.6 -1.5 -8.5
LVP solution [generic name] 48% 7% 23% 5.4 0.5 -2.2
Magnesium sulfate [generic name] 15% -6% 7% 1.8 -0.5 -1.4
Lorazepam [generic name] 12% -6% 0% 3.2 -1.3 -2.7
Proton pump inhibitors [drug category] 24% -6% 17% 5.1 0.0 -0.6
Thyroid hormone measurement (procedure) 13% -7% -24% 1.1 0.0 -0.1
Oxycodone [generic name] 10% -9% 4% 15.9 5.3 -0.8
Magnesium measurement (procedure) 37% -10% -14% 2.1 -0.2 -1.0

* Only high volume conditions or opportunities are represented. For more detail, see the online version.

Confidential - Use Restricted by Agreement Created on 02/23/2011 Page 2 of 2